Molecular Pain
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | 3.8 | Q2 | 64.9% | 1.058 | Q1 | 85.3% |
| 2024 | 2.8 | Q3 | 48.7% | 0.852 | Q1 | 79.8% |
| 2023 | 2.8 | Q2 | 50.0% | 0.904 | Q1 | 83.0% |
| 2022 | 3.3 | Q3 | 47.2% | 0.824 | Q1 | 81.4% |
| 2021 | 3.4 | Q3 | 41.6% | 0.761 | Q1 | 79.8% |
| 2020 | — | — | 1.081 | Q1 | 87.0% | |
| 2019 | — | — | 1.117 | Q1 | 88.0% | |
| 2018 | — | — | 1.160 | Q1 | 87.3% | |
Impact history
Annual SJR and Impact Factor trend.
SJRIF
Journal record
ISSN
1744-8069
country
GBcoverage
2005-2026